Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Capricor Therapeutics (CAPR) Other Non Operating Income (2021)

Capricor Therapeutics has reported Other Non Operating Income over the past 4 years, most recently at $318160.0 for Q2 2021.

  • Quarterly results put Other Non Operating Income at $318160.0 for Q2 2021, changed N/A from a year ago — trailing twelve months through Jun 2021 was $82647.0 (changed N/A YoY), and the annual figure for FY2025 was -$112098.0, down 6.42%.
  • Other Non Operating Income for Q2 2021 was $318160.0 at Capricor Therapeutics, up from $11737.0 in the prior quarter.
  • Over the last five years, Other Non Operating Income for CAPR hit a ceiling of $318160.0 in Q2 2021 and a floor of $318160.0 in Q2 2021.